Paul Abramowitz, PharmD, urged the president to wield the Public Readiness and Emergency Preparedness Act and authorize pharmacists to initiate medications for opioid use disorder and co-prescribe naloxone.
In the letter, Dr. Abramowitz also asked him to “allow physicians to bill for complex evaluation and management services when provided by a pharmacist incident to the physician,” grant prescribers the ability to initiate opioid use disorder medications through telehealth, and allow physicians the option to virtually supervise pharmacists. He seeks for the last two to be made permanent, as they are tied to the soon-to-expire federal COVID-19 public health emergency.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
